Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
02.04. | Bluejay Diagnostics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
28.03. | Bluejay Diagnostics, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
02.03. | Bluejay Diagnostics, Inc. - 8-K, Current Report | - | SEC Filings | ||
03.01. | Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering | 1 | GlobeNewswire (USA) | ||
28.12.23 | Why BlueJay Diagnostics Stock Is Falling | 2 | Benzinga.com | ||
28.12.23 | Bluejay Diagnostics stock plummets on pricing $3.5M offering of common stock | 2 | Seeking Alpha | ||
28.12.23 | Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering | 1 | GlobeNewswire (USA) | ||
27.12.23 | Bluejay Diagnostics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
27.12.23 | Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients (SYMON Study) | 184 | GlobeNewswire (Europe) | This Study performs unique rapid on-site measurements of interleukin-6 (IL-6) and positions Company to move forward with multiple initiatives. ACTON, Mass., Dec. 27, 2023 (GLOBE NEWSWIRE) -- Bluejay... ► Artikel lesen | |
21.12.23 | Bluejay Diagnostics, Inc. - S-1/A, General form for registration of securities | 1 | SEC Filings | ||
21.11.23 | Bluejay Diagnostics files to sell common stocks, warrants | 2 | Seeking Alpha | ||
21.11.23 | Bluejay Diagnostics, Inc. - S-1, General form for registration of securities | 1 | SEC Filings | ||
10.11.23 | Bluejay Diagnostics GAAP EPS of -$2.08 | 1 | Seeking Alpha | ||
09.11.23 | Bluejay Diagnostics, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
09.11.23 | Bluejay Diagnostics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
16.08.23 | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Announces Clinical Update and Reports Second Quarter 2023 Financial Results | 620 | GlobeNewswire (Europe) | ACTON, Mass., Aug. 16, 2023 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) ("Bluejay" or the "Company"), a medical technology company developing rapid diagnostics on its Symphony platform... ► Artikel lesen | |
21.07.23 | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Announces Reverse Stock Split | 473 | GlobeNewswire (Europe) | ACTON, Mass., July 21, 2023 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) ("Bluejay" or the "Company"), a medical technology company developing rapid diagnostics on its Symphony platform... ► Artikel lesen | |
10.05.23 | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Reports First Quarter 2023 Financial Results | 375 | GlobeNewswire (Europe) | ACTON, Mass., May 10, 2023 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) ("Bluejay" or the "Company"), a medical diagnostics company developing rapid tests using whole blood on its Symphony... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SIEMENS HEALTHINEERS | 52,94 | +1,22 % | DZ BANK stuft Siemens Healthineers auf 'Halten' | FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat den fairen Wert für Siemens Healthineers vor Zahlen von 52 auf 53 Euro angehoben und die Einstufung auf "Halten" belassen. Analyst Sven Kürten erwartet... ► Artikel lesen | |
FRESENIUS | 27,210 | +0,11 % | Fresenius und FMC: Aktien im Aufwind - das beflügelt | Die Aktien von Fresenius und ihrer ehemaligen Tochtergesellschaft Fresenius Medical Care (FMC) zeigen am Montag eine robuste Performance. Die Fresenius-Aktie erreichte zwischenzeitlich den höchsten... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 37,420 | -0,98 % | FMC: Erfolge werden deutlicher | Fresenius Medical Care (FMC) erwirtschaftet derzeit rund 70 Prozent des Umsatzes in den USA. Dabei ist das dortige Geschäft überdurchschnittlich profitabel für FMC. Sollte es in dem Land zu Steuersenkungen... ► Artikel lesen | |
CARL ZEISS MEDITEC | 100,30 | +1,31 % | JPMORGAN stuft CARL ZEISS MEDITEC AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Carl Zeiss Meditec vor Zahlen für das zweite Geschäftsquartal auf "Underweight" mit einem Kursziel von 70 Euro belassen. Seine... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 51,83 | -0,86 % | PROCEPT BioRobotics Announces Preliminary Fourth Quarter Revenue of $43.3 million to $43.6 million | SAN JOSE, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
GERRESHEIMER | 100,50 | +1,31 % | Gerresheimer wieder dreistellig - Jefferies hebt den Daumen | Zum Wochenauftakt geht es für die Gerresheimer-Aktie um zwei Prozent nach oben. Nach einem leichtem Rücksetzer notieren die Scheine damit wieder über 100 Euro. Grund für den Aufschlag ist ein positiver... ► Artikel lesen | |
PROGYNY | 32,040 | -1,42 % | Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report | ||
MOBILE-HEALTH NETWORK SOLUTIONS | 23,890 | +0,46 % | APAC Telehealth Leader MNDR Expects Revenue Growth in H12024 vs H12023 | SINGAPORE, April 22, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("Mobile-Health" or the "Company"), a pioneering Asia-Pacific ("APAC") telehealth provider, today provided... ► Artikel lesen | |
NEWGENIVF GROUP | 1,780 | +36,92 % | Pre-market Movers: Tevogen Bio, Freight Technologies, NewGenIvf Group, Snap, U.S. Silica | MOUNTAIN VIEW (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 09.15 A.M. ET).In the Green Tevogen Bio Holdings Inc. (TVGN) is up over... ► Artikel lesen | |
ATRICURE | 23,170 | +2,48 % | AtriCure upgraded at Oppenheimer on valuation | ||
ADAPTHEALTH | 9,960 | +3,97 % | AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2023 Results and Provides Initial 2024 Outlook | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen | |
BRIGHTSPRING HEALTH SERVICES | 10,580 | +1,63 % | BrightSpring Health Services appoints Timothy Wick to its board of directors | ||
LIFEMD | 11,950 | +10,44 % | LifeMD, Inc.: LifeMD to Report First Quarter 2024 Financial Results on May 8 | ||
ECKERT & ZIEGLER | 36,720 | +1,89 % | Eckert & Ziegler: Gewinnanstieg zum Jahresauftakt | Vorläufigen Zahlen zufolge hat Eckert & Ziegler im ersten Quartal 2024 einen Umsatzanstieg von 57,9 Millionen Euro auf 67,6 Millionen Euro verbucht. Das Berliner Radiopharma-Unternehmen meldet zudem... ► Artikel lesen | |
GOODRX | 7,190 | +1,55 % | GoodRx Reports Fourth Quarter and Full Year 2023 Results | SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading destination for prescription savings in the U.S., has released its financial... ► Artikel lesen |